LENSAR, INC. Contract Liability (Deferred Revenue)
LENSAR, INC. (LNSR) had Contract Liability (Deferred Revenue) of $2.93 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-13
- 2026-06-30: Contract with Customer, Liability, Current $2.93M.
- 2026-03-31: Contract with Customer, Liability, Current $3.01M.
- 2025-12-31: Contract with Customer, Liability, Current $3.07M.
- 2025-09-30: Contract with Customer, Liability, Current $2.34M.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $2.93M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.01M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $3.07M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $2.34M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $2.53M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.99M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.68M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.44M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.41M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $1.58M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.35M 10-K · filed 2025-02-27 |
| 2023-09-30 | $1.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $1.07M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $1.03M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $768.00K 10-K · filed 2024-03-04 |
| 2022-09-30 | $789.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $937.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $989.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $904.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $922.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.07M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $967.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $923.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $836.00K 10-Q · filed 2020-11-12 |
| 2019-12-31 | $777.00K 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |